Items where Author is "Alip, A."

Article

Chai, Chee Shee and Liam, Chong Kin and Lin, O. Po and Pang, Yong Kek and Ho, G. F. and Alip, A. and Wong, C. K. and Poh, M. E. (2019) Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma. Annals of oncology, 30 (9). p. 164. ISSN 0923-7534

Chai, Chee Shee and Lin, O. Po and Liam, Chong Kin and Pang, Yong Kek and Ho, G. F. and Alip, A. and Wong, Chee Kuan and Poh, Mau Ern and Tan, Jiunn Liang (2019) Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib. Annals of oncology, 30 (9). p. 167. ISSN 0923-7534

Chai, Chee Shee and Liam, Chong Kin and Poh, Mau Ern and Ong, D. B. L. and Cheah, P. L. and Pang, Yong Kek and Ho, G. F. and Alip, A. (2019) Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology, 14 (10). S1038. ISSN 1556-0864